EVH
Evolent Health, Inc.
+0.04 (+1.01%)3.78USD615K成交股數427M市值–本益比(近四季)0.2股價營收比+46.9%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 653M+47% | 496M+3% | 469M-28% | 480M-23% | 444M-31% | 484M-24% | 647M+16% | 621M+22% | 647M | 640M | 556M | 511M |
| 營業成本 | 572M | 412M | – | 380M | 344M | 381M | – | 541M | 540M | 536M | – | 387M |
| 毛利 | 80.8M-19% | 83.8M-18% | – | 99.8M+24% | 100M-6% | 102M-2% | – | 80.7M-35% | 107M | 104M | – | 124M |
| 毛利率 | 12.4% | 16.9% | – | 20.8% | 22.6% | 21.2% | – | 13.0% | 16.5% | 16.3% | – | 24.3% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 68.8M | 72.8M | – | 77.6M | 75.2M | 78.4M | – | 67.1M | 69.2M | 79.1M | – | 96.6M |
| 營業利益 | −9.6M+716% | −10.6M+553% | – | 886K-105% | −1.2M-115% | −1.6M-88% | – | −16.3M-9% | 7.8M | −13.4M | – | −17.9M |
| 營業利益率 | -1.5% | -2.1% | – | 0.2% | -0.3% | -0.3% | – | -2.6% | 1.2% | -2.1% | – | -3.5% |
| 稅後淨利 | −28.4M+43% | −26.6M-59% | −429M+1782% | −20.9M-10% | −19.9M-1347% | −64.6M+274% | −22.8M-32% | −23.1M-9% | 1.6M | −17.3M | −33.4M | −25.3M |
| 淨利率 | -4.3% | -5.4% | -91.6% | -4.4% | -4.5% | -13.4% | -3.5% | -3.7% | 0.2% | -2.7% | -6.0% | -5.0% |
| 稀釋 EPS | -0.25-43% | -0.24-62% | -3.84+1322% | -0.24-11% | -0.44+633% | -0.63+186% | -0.27-25% | -0.27-10% | -0.06 | -0.22 | -0.36 | -0.30 |
| 稀釋股數 | 113M | 112M | – | 114M | 116M | 115M | – | 115M | 115M | 114M | – | 112M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 116M | 142M | 152M | 117M | 151M | 247M | 104M | 96.6M | 101M | 165M | 193M | 185M |
| 應收帳款 | 449M | 314M | 310M | 387M | 359M | 430M | 415M | 408M | 374M | 428M | 447M | 394M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 2.0B | 1.9B | 1.9B | 2.5B | 2.5B | 2.7B | 2.5B | 2.5B | 2.5B | 2.6B | 2.7B | 2.7B |
| 有息負債 | 966M | 973M | 971M | 1.1B | 648M | 648M | 491M | 600M | 599M | 598M | 597M | 600M |
| 總負債 | 1.6B | 1.5B | 1.5B | 1.6B | 1.3B | 1.5B | 1.4B | 1.3B | 1.2B | 1.4B | 1.4B | 1.4B |
| 股東權益 | 383M | 396M | 415M | 842M | 896M | 936M | 1.0B | 1.0B | 1.1B | 1.0B | 1.1B | 1.1B |
| 負債比 | 80.6% | 78.9% | 78.1% | 65.7% | 54.3% | 57.5% | 53.2% | 51.0% | 50.0% | 53.5% | 53.5% | 52.4% |
| 淨現金(現金 − 有息負債) | −851M | −831M | −819M | −938M | −497M | −401M | −386M | −503M | −498M | −433M | −404M | −415M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −984K-122% | – | – | – | 4.6M-7% | – | – | – | 4.9M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 21.6M | 21.6M | – | 23.6M | 23.1M | 24.1M | – | 29.7M | 29.9M | 29.5M | – | 32.4M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.8B
| Evolent Health Services | 1.9B | 50.0% | -26.6% |
|---|---|---|---|
| Reportable | 1.9B | 50.0% | -26.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.9B | -26.6% | −579M | -30.9% | -5.07 | – |
| FY2024 | 2.6B | +30.1% | −93.5M | -3.7% | -0.81 | – |
| FY2023 | 2.0B | +45.3% | −142M | -7.2% | -1.28 | – |
| FY2022 | 1.4B | +48.9% | −19.2M | -1.4% | -0.20 | – |
| FY2021 | 908M | -1.8% | −37.6M | -4.1% | -0.44 | – |
| FY2020 | 925M | +9.2% | −334M | -36.1% | -3.94 | – |
| FY2019 | 846M | +35.0% | −302M | -35.7% | -3.67 | −78.2M |
| FY2018 | 627M | – | −52.7M | -8.4% | -0.68 | −60.2M |